Product Launch - Dr Lal Pathlabs Ltd

BSE: 539524 NSE:

Dr. Lal PathLabs Becomes South Asia’s First Diagnostic Chain to Launch Advanced Test for Amyloidosis. Dr. Lal PathLabs Limited has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry a breakthrough test for accurately identifying different types of Amyloid proteins. With this launch, DLPL becomes the first diagnostic chain in South Asia to offer this highly specialized test Key Highlights: a) First-of-its-kind in South Asia – DLPL pioneers this advanced diagnostic solution. b) Nationwide Availability – Samples can be collected from anywhere in India and sent to National Reference Lab, Rohini, New Delhi for testing. c) Accurate Diagnosis – Helps doctors determine the specific type of Amyloid, enabling targeted treatment and better outcomes. d) Access for Hospitals – All hospitals can facilitate sample collection for patients and send to Dr Lal PathLabs for testing.